Health TrialsbyHealthPanel

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

ConditionThymoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorFudan University

About this trial

This study is designed to investigate whether adjuvant radiotherapy after complete resection has a better survival for stage II or III thymoma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • adjuvant radiotherapy

    Radiation

    50Gy/25Fx

Treatment groups

238 Participants
are divided into 2 treatment groups
Group A: radiotherapy groupExperimental treatment 1 intervention
Group B: observation groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

DFS (Disease free survival)

from registration to disease progression or death.

Time frame
5 years

Secondary outcomes

1

OS(overall survival)

from registration to death

Time frame
5 years
2

Number of Participants with Treatment- Related Adverse Events as Assessed by CTCAE v4.0

Adverse Events Assessed by CTCAE v4.0

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fudan University

Lead sponsor

Source ClinicalTrials.gov
Apply now